Novartis New Organizational Model

1 Integrating Pharma and Oncology with separate US and International units to increase focus, competitiveness and synergies FROM: Separate Pharma and Oncology organizations adding complexity President PHARMA President ONCOLOGY Global functions Global functions Regions / Key Countries Clusters Regions Clusters Countries Countries TO: Reduced complexity and redundancies, while elevating US business IM International IM US IM Int. Regions / large markets Global marketing functions US Commercial Ops IM Int. Clusters / Countries Goal to be top 5 in the US + maintain leadership Internationally 8. NOVARTIS NEW ORGANIZATIONAL MODEL | APRIL 04, 2022 | NOVARTIS INVESTOR PRESENTATION NOVARTIS | Reimagining Medicine

View entire presentation